These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 10529324)
21. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings. Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835 [TBL] [Abstract][Full Text] [Related]
22. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. McLaughlin MG; Stone GW; Aymong E; Gardner G; Mehran R; Lansky AJ; Grines CL; Tcheng JE; Cox DA; Stuckey T; Garcia E; Guagliumi G; Turco M; Josephson ME; Zimetbaum P; J Am Coll Cardiol; 2004 Sep; 44(6):1215-23. PubMed ID: 15364322 [TBL] [Abstract][Full Text] [Related]
23. [Prognostic value of noninvasive makers of coronary reperfusion in patients with acute myocardial infarction treated with thrombolysis]. Corbalán R; Chávez E; Prieto JC; Castro P; Yovanovich J; Nazzal C; Cumsille F Rev Med Chil; 1996 Dec; 124(12):1423-30. PubMed ID: 9334475 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547 [TBL] [Abstract][Full Text] [Related]
25. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. Scirica BM; Sabatine MS; Morrow DA; Gibson CM; Murphy SA; Wiviott SD; Giugliano RP; McCabe CH; Cannon CP; Braunwald E J Am Coll Cardiol; 2006 Jul; 48(1):37-42. PubMed ID: 16814646 [TBL] [Abstract][Full Text] [Related]
26. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA). Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130 [TBL] [Abstract][Full Text] [Related]
27. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653 [TBL] [Abstract][Full Text] [Related]
28. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444 [TBL] [Abstract][Full Text] [Related]
29. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011 [TBL] [Abstract][Full Text] [Related]
30. Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of Thrombolysis. Zeymer U; Neuhaus KL; Wegscheider K; Tebbe U; Molhoek P; Schröder R J Am Coll Cardiol; 1998 Oct; 32(4):876-81. PubMed ID: 9768705 [TBL] [Abstract][Full Text] [Related]
31. [Prehospital thrombolysis for the treatment of ST-elevation acute myocardial infarction. Three-year results in the province of Foggia]. Piancone RM; Abbenante G; Accettulli-Bocola FA; Bevere A; Casavecchia G; Cervini A; Ciavatta M; De Luca A; De Luca P; Ferrua B; Leccisotti S; Marangi M; Placentino M; Sollazzo V; Tricarico L G Ital Cardiol (Rome); 2008 Nov; 9(11):763-9. PubMed ID: 19058668 [TBL] [Abstract][Full Text] [Related]
32. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials. De Luca G; Biondi-Zoccai G; Marino P Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496 [TBL] [Abstract][Full Text] [Related]
34. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T; Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434 [TBL] [Abstract][Full Text] [Related]
35. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction. Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028 [TBL] [Abstract][Full Text] [Related]
37. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B; Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228 [TBL] [Abstract][Full Text] [Related]
38. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. Schröder R; Dissmann R; Brüggemann T; Wegscheider K; Linderer T; Tebbe U; Neuhaus KL J Am Coll Cardiol; 1994 Aug; 24(2):384-91. PubMed ID: 8034872 [TBL] [Abstract][Full Text] [Related]
39. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532 [TBL] [Abstract][Full Text] [Related]
40. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial). Sejersten M; Ripa RS; Maynard C; Wagner GS; Andersen HR; Grande P; Mortensen LS; Clemmensen P Am J Cardiol; 2006 Mar; 97(5):611-6. PubMed ID: 16490423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]